Peptide Library

FDA-approved

Digestive & weight

Octreotide

Evidence

FDA approved

Class

Somatostatin analog

/

Octreotide

KEY TAKEAWAY

Octreotide is an eight-amino-acid synthetic version of somatostatin that lasts much longer than the natural hormone. It is sold as Sandostatin and Mycapssa. The FDA approved octreotide (Sandostatin) in 1988. It is approved for acromegaly and for symptoms of certain neuroendocrine tumors, and an oral form (Mycapssa) is approved for acromegaly.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Somatostatin analog

Approved for

Acromegaly and symptoms of certain neuroendocrine tumors

Key fact

The FDA approved octreotide (Sandostatin) in 1988. It is approved for acromegaly and for symptoms of certain neuroendocrine tumors, and an oral form (Mycapssa) is approved for acromegaly.

Route

Injection under the skin or into muscle; an oral capsule is also approved

Evidence strength

FDA approved

What it is

What it is

Octreotide is an eight-amino-acid synthetic version of somatostatin that lasts much longer than the natural hormone. It is sold as Sandostatin and Mycapssa.

How it works

How it works

It binds somatostatin receptors and slows the release of growth hormone, insulin, glucagon and several gut hormones.

Regulatory status

Regulatory status

The FDA approved octreotide (Sandostatin) in 1988. It is approved for acromegaly and for symptoms of certain neuroendocrine tumors, and an oral form (Mycapssa) is approved for acromegaly.

What it is used for

What it is used for

Acromegaly and symptoms of certain neuroendocrine tumors.

Side effects and risks

Side effects and risks

Gallstones, nausea, diarrhea and changes in blood sugar are the most common effects.

Citations

Citations

U.S. FDA prescribing information for Octreotide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo